Health Care · Health Care Equipment

Haemonetics Corporation HAE

$82.63+2.71 (+3.40%)delayed quote · as of 2026-07-28 17:10 UTC

Open HAE in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$3.8B

Previous close

$79.91

Volume

352K

52-week range

$47.32 – $87.32

Verdictconfidence 100% · high

Solid footing across most dimensions.

5 of 5 dimensions score well.

Value804/5 checks

Growth603/5 checks

Quality1005/5 checks

Health603/5 checks

Momentum804/5 checks

Fair-value estimate $330.01 per share (2-stage FCF · individual beta · 10Y Rf 4.7%) — the price sits 75% below it.

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2026

Value

P/E TTM

40.3

P/E FWD

14.7

EV/EBITDA TTM

17.6

PEG

0.61

FCF yield FY2026

6.9%

Growth

Revenue 3y

+4.5%/yr

Revenue YoY

−2.0%

Expected EPS

+174.4%

Quality

Piotroski F

6 / 9

ROIC

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-28 17:10 UTC · fundamentals FY 2026 · SEC EDGAR

Verdict

Reading HAE’s filed statements…

Continue with HAE in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.